ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.188,34
-1,00%
S&P 500
5.214,08
0,51%
US Dollar vs BRL
5,1423
0,00%
Bitcoin
62.805,54
-0,39%
Brent Oil
84,075
0,15%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Zivo Bioscience Inc (ZIVO)

  7. Zivo Bioscience Inc (ZIVO) Notícias

ZIVO

Zivo Bioscience (ZIVO)

Zivo Bioscience Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:ZIVO
DataHoraFonteTítuloCódigoCompanhia
26/04/202414:36Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:ZIVOZivo Bioscience Inc
26/04/202409:05Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ZIVOZivo Bioscience Inc
26/04/202409:00Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ZIVOZivo Bioscience Inc
09/04/202412:49Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ZIVOZivo Bioscience Inc
14/03/202410:16Edgar (US Regulatory)Form SCHEDULE 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ZIVOZivo Bioscience Inc
15/02/202418:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZIVOZivo Bioscience Inc
15/02/202410:54Edgar (US Regulatory)Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securitiesNASDAQ:ZIVOZivo Bioscience Inc
07/02/202418:54Business WireZIVO Bioscience Reports Additional Findings from Positive 42-Day Coccidiosis Challenge StudyNASDAQ:ZIVOZivo Bioscience Inc
29/01/202410:00Business WireZIVO Bioscience Announces Uplisting to OTCQB MarketNASDAQ:ZIVOZivo Bioscience Inc
22/01/202419:15Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:ZIVOZivo Bioscience Inc
04/01/202418:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZIVOZivo Bioscience Inc
13/11/202318:18Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ZIVOZivo Bioscience Inc
03/11/202311:18Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:ZIVOZivo Bioscience Inc
30/10/202309:30Business WireZIVO Bioscience Initiates 42-Day Validation Study with Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler ChickensNASDAQ:ZIVOZivo Bioscience Inc
26/10/202309:30Business WireZIVO Bioscience Announces Reverse Stock SplitNASDAQ:ZIVOZivo Bioscience Inc
04/10/202318:08Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:ZIVOZivo Bioscience Inc
03/10/202309:30GlobeNewswire Inc.ZIVO Bioscience to Present at the Dawson James Small Cap Growth ConferenceNASDAQ:ZIVOZivo Bioscience Inc
21/09/202310:35GlobeNewswire Inc.Dawson James Securities Announces October Date for 8th Annual Small Cap Growth ConferenceNASDAQ:ZIVOZivo Bioscience Inc
19/09/202317:15Business WireTrial Results Confirm Efficacy of ZIVO Bioscience’s Non-Antibiotic Product Candidate for the Prevention and Treatment of Coccidiosis in Broiler ChickensNASDAQ:ZIVOZivo Bioscience Inc
16/08/202316:00Business WireZIVO Announces Commitment by ZWorldwide to Purchase all Zivolife™ Algal Biomass Product Produced Over the Next 18 MonthsNASDAQ:ZIVOZivo Bioscience Inc
04/08/202301:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ZIVOZivo Bioscience Inc
03/08/202317:34Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ZIVOZivo Bioscience Inc
26/07/202317:15Business WireZIVO Commences Sales of its Proprietary Algal Biomass as Human FoodNASDAQ:ZIVOZivo Bioscience Inc
17/07/202317:07Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:ZIVOZivo Bioscience Inc
05/07/202308:21Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ZIVOZivo Bioscience Inc
30/06/202314:55Business WireZIVO Bioscience Announces Pricing of $4.0 Million Registered Direct Offering Priced At-The-MarketNASDAQ:ZIVOZivo Bioscience Inc
28/06/202317:11Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:ZIVOZivo Bioscience Inc
28/06/202317:10Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:ZIVOZivo Bioscience Inc
16/06/202307:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ZIVOZivo Bioscience Inc
30/05/202309:45Business WireZIVO’s GRAS Designation Reaffirmed for Proprietary Algal Biomass Product as a Human Food IngredientNASDAQ:ZIVOZivo Bioscience Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:ZIVO

Seu Histórico Recente

BOV
VVEO3
CM Hospitalar ON
BOV
HBRE3
HBR Realty Empreendiment... ON
BOV
IFCM3
Infracommerce Caxaas ON
BOV
TELB4
TELEBRAS PN
BOV
IBOV
Índice Bovespa
BOV
CASH3
Meliuz S.A ON
BOV
MGLU3
MAGAZINE LUIZA ON
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
PRIO3
PETRORIO ON
BOV
COGN3
COGNA ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados